Irinocon
On the Bulgarian pack: Иринокон 100 mg/5 ml концентрат за инфузионен разтвор
100 mg/5 ml · concentrate for solution for infusion
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Irinotecan
- Made by
- Farmakons AD
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States1 matching products
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Farmakons AD · Bulgaria |
|---|---|
| Active substance | Irinotecan |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 100 mg/5 ml |
| Form | concentrate for solution for infusion |
| Pack sizes | 1 |
| Classification | L01CE02 · Cancer treatments and immune-system medicines |
| Name in the register | Иринокон 100 mg/5 ml концентрат за инфузионен разтвор |
| Reg. no. | 20250170 |
Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician
Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.